Literature DB >> 23065853

Influence of age on prognosis of young patients with uveal melanoma: a matched retrospective cohort study.

Swathi Kaliki1, Carol L Shields, Arman Mashayekhi, Anuradha Ganesh, Minoru Furuta, Jerry A Shields.   

Abstract

PURPOSE: To determine the influence of patient age on life prognosis in patients with uveal melanoma.
DESIGN: Matched retrospective cohort study of 122 patients in each age category (young [≤20 years], mid-adults [21-60 years], older adults [>60 years]).
RESULTS: Kaplan-Meier estimates of tumor-related metastasis at 3, 5, and 10 years were 1%, 8%, and 8% in young; 8%, 11%, and 26% in mid-adults; and 13%, 16%, and 24% in older adults. After exclusion of iris melanoma, Kaplan-Meier estimates of tumor-related metastasis at 3, 5, and 10 years were 2%, 11%, and 18% in young; 9%, 14%, and 21% in mid-adults; and 9%, 34%, and 33% in older adults. Risk factors for metastasis based on multivariate analysis included increasing age in young (p=0.05, hazard ratio [HR] 1.33), male gender in mid-adults (p=0.046, HR 4.23), and larger tumor basal diameter in mid-adults (p=0.002, HR 1.37) and older adults (p=0.001, HR 1.30). After adjusting for tumor diameter, the metastatic rate was lower in young patients compared to mid-adults (0=0.042, HR 3.00) and older adults (p=0.007, HR 4.20).
CONCLUSIONS: Younger patient age at the time of diagnosis of uveal melanoma is associated with lower rate of metastasis compared to mid-adults and older adults.

Entities:  

Mesh:

Year:  2013        PMID: 23065853     DOI: 10.5301/ejo.5000200

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   2.597


  16 in total

1.  Clinical Features, Metastasis, and Survival in Patients Younger Than 21 Years With Posterior Uveal Melanoma.

Authors:  Matthew V Fry; James J Augsburger; Zélia M Corrêa
Journal:  JAMA Ophthalmol       Date:  2019-01-01       Impact factor: 7.389

Review 2.  Uveal melanoma: relatively rare but deadly cancer.

Authors:  S Kaliki; C L Shields
Journal:  Eye (Lond)       Date:  2016-12-02       Impact factor: 3.775

Review 3.  Imaging of Uveal Melanoma-Current Standard and Methods in Development.

Authors:  Małgorzata Solnik; Natalia Paduszyńska; Anna M Czarnecka; Kamil J Synoradzki; Yacoub A Yousef; Tomasz Chorągiewicz; Robert Rejdak; Mario Damiano Toro; Sandrine Zweifel; Katarzyna Dyndor; Michał Fiedorowicz
Journal:  Cancers (Basel)       Date:  2022-06-27       Impact factor: 6.575

Review 4.  [Uveal and iridociliary melanomas in young patients : A retrospective analysis of 57 cases].

Authors:  L J Heyer; C Metz; D Flühs; C M Heyer; N Bornfeld
Journal:  Ophthalmologe       Date:  2016-12       Impact factor: 1.059

5.  Uveal melanoma in children and teenagers.

Authors:  Carol L Shields; Swathi Kaliki; Sruthi Arepalli; Hatice Tuba Atalay; Fairooz P Manjandavida; Guilia Pieretti; Jerry A Shields
Journal:  Saudi J Ophthalmol       Date:  2013-07-05

6.  A Novel 8-Gene Prognostic Signature for Survival Prediction of Uveal Melanoma.

Authors:  Zhongjun Tang; Kebo Cai
Journal:  Anal Cell Pathol (Amst)       Date:  2021-08-14       Impact factor: 2.916

Review 7.  Uveal melanoma: estimating prognosis.

Authors:  Swathi Kaliki; Carol L Shields; Jerry A Shields
Journal:  Indian J Ophthalmol       Date:  2015-02       Impact factor: 1.848

Review 8.  Posterior uveal melanoma in adolescents and children: current perspectives.

Authors:  Matthew V Fry; James J Augsburger; June Hall; Zélia M Corrêa
Journal:  Clin Ophthalmol       Date:  2018-11-07

Review 9.  Robot-assisted laparoscopic surgery for abdominal metastatic melanoma mimicking a gastrointestinal stromal tumor: A case report and review of the literature.

Authors:  Zhou Ye; Zhe Yang; Shusen Zheng; Weilin Wang
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

10.  Clinical Characteristics of 582 Patients with Uveal Melanoma in China.

Authors:  Yue Ming Liu; Yang Li; Wen Bin Wei; Xiaolin Xu; Jost B Jonas
Journal:  PLoS One       Date:  2015-12-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.